Emi Tokuda

818 total citations
36 papers, 581 citations indexed

About

Emi Tokuda is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Emi Tokuda has authored 36 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 12 papers in Molecular Biology. Recurrent topics in Emi Tokuda's work include Advanced Breast Cancer Therapies (8 papers), Breast Cancer Treatment Studies (7 papers) and Breast Lesions and Carcinomas (6 papers). Emi Tokuda is often cited by papers focused on Advanced Breast Cancer Therapies (8 papers), Breast Cancer Treatment Studies (7 papers) and Breast Lesions and Carcinomas (6 papers). Emi Tokuda collaborates with scholars based in Japan, United States and United Kingdom. Emi Tokuda's co-authors include Kristi S. Anseth, Jennifer L. Leight, Mitsue Saito, Yoshiya Horimoto, Atsushi Arakawa, Katsuya Nakai, Tadaomi Takenawa, Masahiko Tanabe, Fujio Kasumi and Hideo Shimizu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Biomaterials.

In The Last Decade

Emi Tokuda

33 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emi Tokuda Japan	14	256	224	177	121	113	36	581
Alison G. Barber United States	6	256 1.0×	413 1.8×	170 1.0×	79 0.7×	68 0.6×	8	639
Yura Song Belgium	10	157 0.6×	218 1.0×	109 0.6×	133 1.1×	67 0.6×	14	537
Thanh Huong Nguyen Ho-Bouldoires France	8	216 0.8×	245 1.1×	153 0.9×	172 1.4×	53 0.5×	8	624
Karl‐Ludwig Schäfer Germany	12	241 0.9×	268 1.2×	100 0.6×	69 0.6×	111 1.0×	13	637
Sonja M. Markwart United States	15	240 0.9×	459 2.0×	178 1.0×	89 0.7×	148 1.3×	15	847
Lidija Jovanovic Australia	13	279 1.1×	199 0.9×	225 1.3×	32 0.3×	164 1.5×	22	561
Aaron Boudreau United States	10	226 0.9×	418 1.9×	182 1.0×	218 1.8×	80 0.7×	14	776
Reeti Behera United States	7	175 0.7×	227 1.0×	97 0.5×	125 1.0×	42 0.4×	10	571
Jonathon D. Roybal United States	10	236 0.9×	433 1.9×	300 1.7×	144 1.2×	62 0.5×	11	739
Taronish D. Dubash United States	12	287 1.1×	360 1.6×	168 0.9×	77 0.6×	51 0.5×	15	685

Countries citing papers authored by Emi Tokuda

Since Specialization

Citations

This map shows the geographic impact of Emi Tokuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emi Tokuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emi Tokuda more than expected).

Fields of papers citing papers by Emi Tokuda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emi Tokuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emi Tokuda. The network helps show where Emi Tokuda may publish in the future.

Co-authorship network of co-authors of Emi Tokuda

This figure shows the co-authorship network connecting the top 25 collaborators of Emi Tokuda. A scholar is included among the top collaborators of Emi Tokuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emi Tokuda. Emi Tokuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kuroda, Junko, Masayoshi Oikawa, Emi Tokuda, et al.. (2024). Development of cancer therapy-related cardiac dysfunction in anthracycline-treated breast cancer patients: a retrospective study. Supportive Care in Cancer. 33(1). 8–8. 1 indexed citations

Kojima, Yuki, et al.. (2023). The Impact of Being Underweight on the Prognosis of Older Patients With Early Breast Cancer. Cancer Diagnosis & Prognosis. 3(6). 678–686. 1 indexed citations

Shimomura, Akihiko, Emi Tokuda, Yoshiya Horimoto, et al.. (2022). Is adjuvant chemotherapy necessary in older patients with breast cancer?. Breast Cancer. 29(3). 498–506. 6 indexed citations

Tokuda, Emi, et al.. (2020). Abstract PD2-04: Different mechanism of CDK4/6 inhibitor resistance between ribociclib and abemaciclib. Cancer Research. 80(4_Supplement). PD2–4. 2 indexed citations

Horimoto, Yoshiya, et al.. (2019). Impact of circulating tumour cells on survival of eribulin-treated patients with metastatic breast cancer. Medical Oncology. 36(10). 89–89. 14 indexed citations

Horimoto, Yoshiya, Masahiko Tanabe, Yuko Ichikawa, et al.. (2018). Predictive markers for efficacy of everolimus plus exemestane in patients with luminal HER2-negative metastatic breast cancer. Medical Oncology. 35(4). 48–48. 7 indexed citations

Horimoto, Yoshiya, Emi Tokuda, Katsuya Nakai, et al.. (2018). Analysis of circulating tumour cell and the epithelial mesenchymal transition (EMT) status during eribulin-based treatment in 22 patients with metastatic breast cancer: a pilot study. Journal of Translational Medicine. 16(1). 287–287. 51 indexed citations

Tokuda, Emi, et al.. (2017). Differences in Ki67 expressions between pre- and post-neoadjuvant chemotherapy specimens might predict early recurrence of breast cancer. Human Pathology. 63. 40–45. 26 indexed citations

Horimoto, Yoshiya, Atsushi Arakawa, Joe Matsuoka, et al.. (2016). Activated Caspase 3 Expression in Remnant Disease After Neoadjuvant Chemotherapy May Predict Outcomes of Breast Cancer Patients. Annals of Surgical Oncology. 23(7). 2235–2241. 10 indexed citations

10.

Horimoto, Yoshiya, Atsushi Arakawa, Masahiko Tanabe, et al.. (2015). Menstrual cycle could affect Ki67 expression in estrogen receptor-positive breast cancer patients. Journal of Clinical Pathology. 68(10). 825–829. 10 indexed citations

11.

Shimizu, Hideo, Yoshiya Horimoto, Atsushi Arakawa, et al.. (2015). Application of a 70-Gene Expression Profile to Japanese Breast Cancer Patients. Breast Care. 10(2). 118–122. 5 indexed citations

12.

Horimoto, Yoshiya, Atsushi Arakawa, Masahiko Tanabe, et al.. (2014). Ki67 expression and the effect of neo-adjuvant chemotherapy on luminal HER2-negative breast cancer. BMC Cancer. 14(1). 550–550. 22 indexed citations

13.

Tokuda, Emi, Jennifer L. Leight, & Kristi S. Anseth. (2014). Modulation of matrix elasticity with PEG hydrogels to study melanoma drug responsiveness. Biomaterials. 35(14). 4310–4318. 60 indexed citations

14.

Horimoto, Yoshiya, Atsushi Arakawa, Narumi Harada‐Shoji, et al.. (2014). Low FOXA1 expression predicts good response to neo-adjuvant chemotherapy resulting in good outcomes for luminal HER2-negative breast cancer cases. British Journal of Cancer. 112(2). 345–351. 26 indexed citations

15.

Schwartz, Michael P., Robert E. Rogers, Samir P. Singh, et al.. (2013). A Quantitative Comparison of Human HT-1080 Fibrosarcoma Cells and Primary Human Dermal Fibroblasts Identifies a 3D Migration Mechanism with Properties Unique to the Transformed Phenotype. PLoS ONE. 8(12). e81689–e81689. 31 indexed citations

16.

Tokuda, Emi, Atsushi Arakawa, Mitsue Saito, et al.. (2011). Estrogen receptor-α directly regulates sensitivity to paclitaxel in neoadjuvant chemotherapy for breast cancer. Breast Cancer Research and Treatment. 133(2). 427–436. 29 indexed citations

17.

Tokuda, Emi, et al.. (2009). RETROPERITONEAL ABSCESS DUE TO PERFORATION OF ILEAL DIVERTICULM-A CASE REPORT-. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 70(7). 2170–2173. 3 indexed citations

18.

Horimoto, Yoshiya, et al.. (2009). Significance of HER2 Protein Examination in Ductal Carcinoma In Situ. Journal of Surgical Research. 167(2). e205–e210. 17 indexed citations

19.

Tokuda, Emi, et al.. (2008). Isolation of Stable (αβ)₄-Tetraprotomer from Na⁺/K⁺-ATPase Solubilized in the Presence of Short-Chain Fatty Acids. Biochemistry. 47(22). 6039–6051. 8 indexed citations

20.

Tokuda, Emi, Naoya Fujita, Tomoko Oh‐hara, et al.. (2007). Casein Kinase 2–Interacting Protein-1, a Novel Akt Pleckstrin Homology Domain-Interacting Protein, Down-regulates PI3K/Akt Signaling and Suppresses Tumor Growth In vivo. Cancer Research. 67(20). 9666–9676. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact